Anonymous ID: 63b9a3 Jan. 14, 2020, 7:45 p.m. No.7817692   🗄️.is 🔗kun

>>7817507

found this by searching "santa muerte" fren

https://kvoa.com/news/2019/12/18/digging-deeper-new-details-in-take-down-of-tucson-drug-trafficking-organization/

https://www.kgun9.com/news/local-news/ups-drug-case-police-say-severed-goat-and-cat-heads-found

Anonymous ID: 63b9a3 Jan. 14, 2020, 8:43 p.m. No.7818100   🗄️.is 🔗kun

Randall Rutta: Discrimination against people with rare diseases

https://triblive.com/opinion/randall-rutta-discrimination-against-people-with-rare-diseases/

https://archive.is/wip/lwaYG

FDA officials approved a record number of rare disease treatments in 2018. One groundbreaking medicine treats an inherited bone condition that causes intense pain and immobility. Another treats Fabry disease, a genetic condition that can lead to kidney failure or stroke.

 

Breakthroughs like these offer hope to 30 million Americans living with rare diseases. But there’s still a long way to go. Scientists estimate there are 7,000 rare diseases, each of which afflicts fewer than 200,000 people. The majority of these ailments — 95% — lack a single approved treatment.

 

Unfortunately, one prominent health care nonprofit could undermine research into rare diseases.

 

The group, the Institute for Clinical and Economic Review (ICER), analyzes the “cost-effectiveness” of many new FDA-approved drugs, including treatments for rare diseases. Because it relies on flawed assumptions, ICER mostly concludes that rare disease treatments aren’t worth the price….